पैरासिटामोल और कोडीन और फ्लुवोक्सामिन का इंटरैक्शन

Serotonin Syndrome Inform patients that opioids could cause a rare but potentially life-threatening condition resulting from concomitant administration of serotonergic drugs.

Examples of these drugs include, selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that affect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (i.e., cyclobenzaprine, metaxalone),…

Instruct patients to inform their healthcare provider if they are taking, or plan to take serotonergic medications ( see PRECAUTIONS, Drug Interactions ).

Serotonergic Drugs The concomitant use of opioids with other drugs that affect the serotonergic neurotransmitter system has resulted in serotonin syndrome.

Methadone: Significantly increased methadone (plasma level:dose) ratios have been reported when fluvoxamine maleate was administered to patients receiving maintenance methadone treatment, with symptoms of opioid intoxication in one patient.

Methadone: Coadministration may produce opioid intoxication.

Discontinuation of fluvoxamine may produce opioid withdrawal ( 5.8 ).

Opioid withdrawal symptoms were reported following fluvoxamine maleate discontinuation in another patient.

Other Serotonergic Drugs: The concomitant use of serotonergic drugs (including other SSRIs, SNRIs, triptans, tricyclic antidepressants, opioids, lithium, buspirone, amphetamines, tryptophan, and St.